1. Treating anaplastic lymphoma kinase (ALK) fusion-driven metastatic non-small cell lung cancer (NSCLC) with alectinib through pregnancy
   Florence Wu et al, 2024, BMJ Case Reports CrossRef
2. Tackling Non–Small Cell Lung Cancer in Young Adults: From Risk Factors and Genetic Susceptibility to Lung Cancer Profile and Outcomes
   Juan Carlos Laguna et al, 2024, American Society of Clinical Oncology Educational Book CrossRef
3. Effective Use of ALK Inhibitors in EML4::ALK‐Positive Lymphatic Malformations
   Beth Apsel Winger et al, 2025, Pediatric Blood & Cancer CrossRef
4. Non-small cell lung cancer with bone metastasis and pneumocystis pneumonia in a pregnant woman: a case report and literature review
   Jie Hu et al, 2023, BMC Infectious Diseases CrossRef
5. Lung Cancer Oncogene-Directed Therapy, Fertility, and Pregnancy
   Emily Simons et al, 2024, Journal of Thoracic Oncology CrossRef
6. ALK Rearrangement Positive Lung Adenocarcinoma in Pregnancy Treated With Alectinib: A Case Report
   Luis F. Gonzalez-Mosquera et al, 2024, Clinical Lung Cancer CrossRef